Abiopharma

Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76

Parsons Awarded $184 Million Navy Intelligence Carry-On Program Contract

Diana Shipping Inc. Addresses Genco Shipping & Trading’s Last-Ditch Attempt to Cling to Poison Pill

Carter’s Launches ‘Dadfirmation Station’ Hotline to Remind Dads They’re Doing a Great Job

Akamai Unveils Agentic Security Framework to Power Trusted AI-Driven Interactions and Commerce

Share Buy Back - Daily Share Buy-Back Notice: S$2Bn Value Realisation Share Buy-back Programme

New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

Change in holdings of interested parties/officers

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Form 6-K- Departure of Board Member- Cynthia L. Paul